reports
Divfex Berhad: 1 director
A director at Divfex Berhad sold 4,870,000 shares at 0.133MYR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
KRM22: 1 director
A director at KRM22 bought 100,000 shares at 25p and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Clos...
Zhongzhi Pharmaceutical Holdings Limited: 1 director
A director at Zhongzhi Pharmaceutical Holdings Limited bought 2,259,000 shares at 1.170HKD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
EQS-News: CureVac and MD Anderson Enter Strategic Collaboration to De...
Issuer: CureVac / Key word(s): Alliance CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines 16.04.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines Agreement creates strong synergies between CureVac’s unique end-to-end mRNA capabilities and MD Anderson’s translational and clinical research expertise Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematologic...
EQS-News: CureVac und MD Anderson gehen strategische Kooperation zur E...
Emittent / Herausgeber: CureVac / Schlagwort(e): Kooperation CureVac und MD Anderson gehen strategische Kooperation zur Entwicklung neuartiger Krebsimpfstoffe ein 16.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CureVac und MD Anderson gehen strategische Kooperation zur Entwicklung neuartiger Krebsimpfstoffe ein Kooperation schafft starke Synergien zwischen einzigartiger mRNA-Kompetenz von CureVac und translationaler und klinischer Forschungsexpertise von MD Anderson Entwicklung neuartiger, „off-the-shelf“ ...
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results fr...
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints Lumateperone 42 mg met the primary endpoint of change from baseline at Week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) total score versus placebo (4.9 point reduction v. placebo; p
Melco International Development: 1 director
A director at Melco International Development bought 1,200,000 shares at 5.700HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
Thanh Thanh Cong - Bien Hoa : 1 director
A director at Thanh Thanh Cong - Bien Hoa sold 15,000,000 shares at 0.000VND and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Hanwha Life Insurance Co Ltd: 1 director
A director at Hanwha Life Insurance Co Ltd bought 20,000 shares at 2,640.000KRW and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Fiera Capital Corp: 1 director
A director at Fiera Capital Corp sold 61,600 shares at 7.800CAD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Nam Song Hau Trading Investing Petroleum Joint Stock Company: 1 direct...
A director at Nam Song Hau Trading Investing Petroleum Joint Stock Company sold 2,017,700 shares at 0.000VND and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the comp...
Barrick On Track to Achieve 2024 Targets
Barrick On Track to Achieve 2024 Targets All amounts expressed in US dollars TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) ("Barrick" or the "Company") today reported preliminary Q1 production of 940 thousand ounces of gold and 40 thousand tonnes of copper, as well as preliminary Q1 sales of 910 thousand ounces of gold and 39 thousand tonnes of copper. As previously guided, Barrick’s gold and copper production in 2024 is expected to progressively increase each quarter through the year, with the Pueblo Viejo plant expansion ramping up from Q2 an...
Company Provides 2024 Results of Operations
Company Provides 2024 Results of Operations Company Generates $29.2 Million in Sales on 9-Month Transition Year Fort Lauderdale, FL, April 16, 2024 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc. (“Singing Machine”) (NASDAQ: MICS) – the worldwide leader in consumer karaoke products, today announced its results of operations for the nine-month period ended December 31, 2023. The Company has historically reported on a March 31 fiscal year end and transitioned to a December 31 fiscal year end with the Transition Period Annual Report released today. “We are pleased to provide a co...
Multitude SE - Managers' transactions - Tiukkanen
Multitude SE - Managers' transactions - Tiukkanen Multitude SE - Managers' transactions - Tiukkanen ____________________________________________ Person subject to the notification requirementName: Tiukkanen, AriPosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_136____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transa...
Multitude SE - Managers' transactions - Kajakas
Multitude SE - Managers' transactions - Kajakas Multitude SE - Managers' transactions - Kajakas ____________________________________________ Person subject to the notification requirementName: Kajakas, KristjanPosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_132____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transac...
Multitude SE - Managers' transactions - Chatterjee
Multitude SE - Managers' transactions - Chatterjee Multitude SE - Managers' transactions - Chatterjee ____________________________________________ Person subject to the notification requirementName: Chatterjee, JuliePosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_129____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE T...
Multitude SE - Managers' transactions - Krause
Multitude SE - Managers' transactions - Krause Multitude SE - Managers' transactions - Krause ____________________________________________ Person subject to the notification requirementName: Krause, ClemensPosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_133____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction...
Multitude SE - Managers' transactions - Mäkelä
Multitude SE - Managers' transactions - Mäkelä Multitude SE - Managers' transactions - Mäkelä ____________________________________________ Person subject to the notification requirementName: Mäkelä, LassePosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_135____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction d...
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host C...
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conferenc...
Gray Television Stations Win Large Market and Small Market Service to ...
Gray Television Stations Win Large Market and Small Market Service to America Awards ATLANTA, April 16, 2024 (GLOBE NEWSWIRE) -- The National Association of Broadcasters Leadership Foundation (“NABLF”) selected two television stations owned by Gray Television, Inc. (NYSE: GTN) for this year’s coveted Service to America Awards. The NABLF’s Service to America Awards recognize outstanding community service by local broadcasters each year for their exemplary service to their communities. The NABLF recognizes the winners in each category at an in-person gala in Washington, DC, on June 4, 2024....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.